Showing results (241-250 of 357) with videos related to
Sort By:
Pageof 36
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: role of nuclear factor-kappaB suppressionJ H Finke, P Rayman, R George, et al.Journal of Cancer Research and Clinical Oncology|May 18, 2001
Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinomaT Olencki, D Peereboom, L Wood, et al.Cancer|December 15, 1987
A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors. A Southwest Oncology Group StudyR M Bukowski, K G Johnson, R F Peterson, et al.Aggressive Behavior|November 18, 2015
Attribution of human characteristics and bullying involvement in childhood: Distinguishing between targetsTirza H J van Noorden, Gerbert J T Haselager, Tessa A M Lansu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancyG T Budd, S Murthy, J Finke, et al.Cancer|May 20, 2008
Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinomaEric Jonasch, Walter M Stadler, Ronald M Bukowski, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1994
A phase I trial of intrapleural recombinant human interferon alpha (rHuIFN alpha 2b) in patients with malignant pleural effusionsA Bhatia, T W Rice, D McLain, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 23, 2000
Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: clinical and biologic effectsT Olencki, J Finke, R Tubbs, et al.Cancer Chemotherapy and Pharmacology|October 6, 2000
A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancerR Pelley, R Ganapathi, L Wood, et al.Journal of the National Cancer Institute|January 5, 2007
Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinibBrian I Rini, Ila Tamaskar, Phillip Shaheen, et al.Pageof 36